Amai Proteins Expands Asia Reach With sweelin®
Rehovot, Israel, May 25, 2026 Amai Proteins has announced a major regulatory breakthrough after receiving approval from the Singapore...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Rehovot, Israel, May 25, 2026 Amai Proteins has announced a major regulatory breakthrough after receiving approval from the Singapore...
BOSTON, May 12, 2026 Servier has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...
OVERLAND PARK, Kan., and BOULDER, Colo., May 12, 2026 Hill’s Pet Nutrition and Bond Pet Foods have announced a...
